0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

How have we been lending a hand to the COVID-19 effort?
June 9, 2020

COVID-19 is undoubtedly having an impact on patient populations. During this challenging time, Talking Medicines have been doing their bit to support the Medsmart® community whilst sharing data insight from greater patient populations to add value to Government data, to help others and raise awareness of the work we are doing.

COVID-19 Tracker

The UK statistics show that there are 15,639 confirmed cases of COVID-19 in Scotland and 155,000, 14,438 and 4,802 in England, Wales and Northern Ireland respectively (The Guardian). To play our part in tracking and to support our Medsmart® community we created a new version of our App – inclusive of a COVID-19 tracker. So far we have had an uptake of 2.82% across our Medsmart® community with a proportion of users confirming that they have tested positive for COVID-19, another group that think they may have COVID-19 and a further subset of users that are using this feature to state that they are unaffected. We are delighted to that there is use of the tracker already and intend to keep this feature in the App over the coming months to support users and add value to coronavirus data as time goes on. The profile of those experiencing symptoms are expressed in the infographic below:

Tracking impact of the pandemic on medicines uploaded to Medsmart®

We have also been looking at the medicines being scanned into our Medsmart® App over the last few months. We can see that over the course of the pandemic the top five medicines uploaded were: Omeprazole, levothyroxine, sertraline, atorvastatin and Ramipril. These drugs are used to treat gastric acid, hypothyroidism, depression, high cholesterol and high blood pressure respectively.

We believe that the data we collect about how people talk about their health and use their medicines can be used for good. It is important to us that we use our tools not only to connect patients with the wider healthcare system but also to connect the healthcare system back to the patients and their voices. We hope that by continuing to collate and structure data from our COVID-19 Tracker and by analysing changes in user medicine uploads we can continue to contribute to the COVID-19 effort as it enters this new “test and trace” phase.

 

Ref: https://www.theguardian.com/world/2020/jun/09/coronavirus-uk-map-the-latest-deaths-and-confirmed-cases-near-you

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...